{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T05:30:28Z","timestamp":1782451828965,"version":"3.54.5"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Purpose<\/jats:title>\n                  <jats:p>Studies have shown the positive impact pharmacist-managed services have on patient care. However, little information is available on services for pregnant patients. This study contributes to the current literature by providing data on the impact of a pharmacist-managed service on outcomes in pregnant patients with iron-deficiency anemia.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This was a retrospective, data-only, multicenter study comparing pregnant patients with iron-deficiency anemia managed by a pharmacist (n = 100) to those who received standard care (n = 100). During the study period, patients were 16 years of age or older and pregnant with concurrent iron-deficiency anemia. The percentage of patients with a hemoglobin level above goal (&amp;gt;11.0 g\/dL) at delivery, the mean hemoglobin level at delivery, and the type of iron supplementation were compared between the groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The percentage of patients with a hemoglobin level of greater than 11.0 g\/dL at delivery was 87% for the pharmacist-managed group compared to 71% for the group receiving standard care (P &amp;lt; 0.01). The mean hemoglobin level at delivery was significantly higher in the pharmacist-managed group than in the group receiving standard care, at 12.1 g\/dL vs 11.6 g\/dL, respectively (P &amp;lt; 0.1). There was no difference between the groups in the percentage of patients receiving blood transfusions (4% vs 3%; P = 0.56). The percentage of patients who received intravenous iron was significantly lower in the pharmacist-managed group than in the group receiving standard care (8% vs 21%; P &amp;lt; 0.01). Most patients in the pharmacist-managed group received oral ferrous sulfate (81%).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>This study showed that including pharmacists in the management of pregnant patients with iron-deficiency anemia significantly improved patient hemoglobin levels at delivery.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajhp\/zxad293","type":"journal-article","created":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T01:55:22Z","timestamp":1700790922000},"page":"S21-S27","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of a pharmacist-managed anemia service in pregnant patients"],"prefix":"10.1093","volume":"81","author":[{"given":"Danielle","family":"Weaver","sequence":"first","affiliation":[{"name":"Pharmacy, Kaiser Permanente San Francisco Medical Center , San Francisco, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunny","family":"Cheung","sequence":"additional","affiliation":[{"name":"Pharmacy, Kaiser Permanente San Francisco Medical Center , San Francisco, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"deLaunay","sequence":"additional","affiliation":[{"name":"Pharmacy, Kaiser Permanente San Rafael Medical Center , San Rafael, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Young","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology, Kaiser Permanente San Francisco Medical Center , San Francisco, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie","family":"Fabian","sequence":"additional","affiliation":[{"name":"Pharmacy, Kaiser Permanente San Francisco Medical Center , San Francisco, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Tieu","sequence":"additional","affiliation":[{"name":"Pharmacy, Kaiser Permanente San Francisco Medical Center , San Francisco, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,11,23]]},"reference":[{"issue":"3","key":"2024052018381351700_CIT0001","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1053\/j.ajkd.2012.04.013","article-title":"Impact of pharmacist-managed erythropoiesis-stimulating agents clinics for patients with non-dialysis-dependent CKD","volume":"60","author":"Aspinall","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"19","key":"2024052018381351700_CIT0002","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1080\/14767058.2017.1349746","article-title":"Anemia and pregnancy outcomes: a longitudinal study","volume":"31","author":"Tunkyi","year":"2018","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"6","key":"2024052018381351700_CIT0003","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1097\/AOG.0000000000003557","article-title":"Maternal and perinatal morbidity and mortality associated with anemia in pregnancy","volume":"134","author":"Smith","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"7","key":"2024052018381351700_CIT0004","first-page":"CD004736","article-title":"Daily oral iron supplementation during pregnancy","volume":"2015","author":"Pe\u00f1a-Rosas","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2024052018381351700_CIT0005","author":"World Health Organization"},{"issue":"13 suppl 8","key":"2024052018381351700_CIT0006","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.2146\/ajhp070183","article-title":"Pharmacist\u2019s role in managing anemia in patients with chronic kidney disease: potential clinical and economic benefits","volume":"64","author":"Gilmartin","year":"2007","journal-title":"Am J Health-Syst Pharm."},{"issue":"7","key":"2024052018381351700_CIT0007","first-page":"715","article-title":"Impact of a clinical pharmacy anemia management service on adherence to monitoring guidelines, clinical outcomes, and medication utilization","volume":"20","author":"Debenito","year":"2014","journal-title":"J Manag Care Spec Pharm"},{"issue":"6","key":"2024052018381351700_CIT0008","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s40258-013-0057-6","article-title":"Incremental cost effectiveness of pharmacist-managed erythropoiesis-stimulating agent clinics for non-dialysis-dependent chronic kidney disease patients","volume":"11","author":"Aspinall","year":"2013","journal-title":"Appl Health Econ Health Policy"},{"issue":"1","key":"2024052018381351700_CIT0009","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/ijpp.12358","article-title":"A randomized control trial to evaluate the clinical pharmacist\u2019s role in managing iron deficiency anemia patients","volume":"26","author":"Tahaineh","year":"2018","journal-title":"Int J Pharm Pract"},{"issue":"2","key":"2024052018381351700_CIT0010","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1097\/AOG.0000000000004477","volume":"138","year":"2021","journal-title":"Obstet Gynecol"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxad293\/54182850\/zxad293.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/81\/Supplement_1\/S21\/57768418\/zxad293.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/81\/Supplement_1\/S21\/57768418\/zxad293.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T18:38:23Z","timestamp":1716230303000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/81\/Supplement_1\/S21\/7444955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,23]]},"references-count":10,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2023,11,23]]},"published-print":{"date-parts":[[2024,2,20]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxad293","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,3,1]]},"published":{"date-parts":[[2023,11,23]]}}}